WAY-100635 Maleate 10 mg | 100.00%
TargetMol
WAY-100635 is a specific and effective 5-HT receptor antagonist (IC50=0.95 nM).
More Information Supplier PageWAY-100635 Maleate
Search Results
Cilastatin 50 mg | 98.21%
TargetMol
Cilastatin is a renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.
More Information Supplier PageCilastatin
Cilastatin 25 mg | 98.21%
TargetMol
Cilastatin is a renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.
More Information Supplier PageCilastatin
Cilastatin 100 mg | 98.21%
TargetMol
Cilastatin is a renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.
More Information Supplier PageCilastatin
Pilaralisib analogue 100 mg | 99.46%
TargetMol
Pilaralisib analogue (XL147 analogue) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.
More Information Supplier PagePilaralisib analogue
Pilaralisib analogue 50 mg | 99.46%
TargetMol
Pilaralisib analogue (XL147 analogue) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.
More Information Supplier PagePilaralisib analogue
Pilaralisib analogue 5 mg | 99.46%
TargetMol
Pilaralisib analogue (XL147 analogue) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.
More Information Supplier PagePilaralisib analogue
HPOB 10 mg | 99.19%
TargetMol
HPOB is an effective and specific HDAC6 inhibitor (IC50: 56 nM), >30-fold selectivity over other HDACs.
More Information Supplier PageHPOB
HPOB 5 mg | 99.19%
TargetMol
HPOB is an effective and specific HDAC6 inhibitor (IC50: 56 nM), >30-fold selectivity over other HDACs.
More Information Supplier PageHPOB
PFK-015 10 mg | 99.70%
TargetMol
PFK-015 (PFK15) is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).
More Information Supplier PagePFK-015
